Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Press Releases
2108 Articles Available
1
88
Can't find what you're looking for? Try our
advanced search
.
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
PR-M10-19-NI-020
Diagnostics
FDA Allows Marketing of First Rapid Diagnostic Test for Detecting Ebola Virus Antigens
PR-M10-19-NI-019
Research
Viagra Helps Mobilize Bone Marrow Stem Cells for Transplantation in Mice
PR-M10-19-NI-018
Clinical Trials
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
PR-M10-19-NI-017
Clinical Trial Partnership
Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials
PR-M10-19-NI-014
Leadership
Biotechnology Innovation Organization Announces 2021 Leadership Transition
PR-M10-19-NI-016
Leadership
LabCorp Announces New Leadership Roles for Its Two Business Segments and Selects New Chief Human Resources Office
PR-M10-19-NI-015
Partnership
Charles River Laboratories Joins Dementia Consortium, Reaffirms Commitment to Neuroscience Research
PR-M10-19-NI-013
Lyophilization
Lyophilization Cycle Development & Optimization: A Hands On Laboratory Course
PR-M10-19-NI-012
Clinical Trials
Sosei Heptares Notes the Announcement of Positive Results from Phase III IRIDIUM Study of Inhaled Combination QVM149 in Patients with Uncontrolled Asthma
PR-M10-19-NI-011
CBD
Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments
PR-M10-19-NI-009
Clinical Results
ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study
PR-M10-19-NI-010
HIV Prevention
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic
PR-M10-19-NI-008
Agreement
Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates
PR-M10-19-NI-006
FDA
FDA Encourages Inclusion of Male Patients in Breast Cancer Clinical Trials
PR-M10-19-NI-005
Clinical Trials
Poorly Reported Placebos May Lead to Mistaken Estimates of Benefits
PR-M10-19-NI-004
Market Prediction
Global $170+ Billion Air Freight (Domestic & International) Market Forecast, 2019-2023
PR-M10-19-NI-003
Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer
PR-M10-19-NI-002
Collaboration
Novartis and Microsoft Announce Collaboration to Transform Medicine with Artificial Intelligence
PR-M10-19-NI-007
Strategic Partnership
TrakCel Announces Strategic Partnership with WuXi AppTec Advanced Therapies for Optimization of Supply Chain for Cell and Gene Therapy Treatments
PR-M10-19-NI-008
Clinical Data
New Data Reinforces Benefits of Spiolto® Respimat® in Improving Patient Outcomes
PR-M10-19-NI-001
Legal Settlement
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission
PR-M09-19-NI-060
Oncology
Blood Test Can Replace Invasive Biopsy for More Patients with Lung Cancer
PR-M09-19-NI-059
Liquid Biopsy
GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study
PR-M09-19-NI-058
1
88
»
